Micro Labs Limited — Diphenhydramine Exporter Profile
Indian Pharmaceutical Exporter · #2 for Diphenhydramine · $1.9M export value · DGFT Verified
Micro Labs Limited is the #2 Indian exporter of Diphenhydramine with $1.9M in export value and 38 verified shipments. Micro Labs Limited holds a 5.9% market share in Diphenhydramine exports across 2 countries. The company exports 76 pharmaceutical products worth $463.6M across 21 therapeutic categories.
Micro Labs Limited — Diphenhydramine Export Profile: Buyers & Destinations
Where Does Micro Labs Limited Export Diphenhydramine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.8M | 36 | 90.6% |
| UNITED STATES OF AMERICA | $100.0K | 2 | 5.1% |
| UNITED ARAB EMIRATES | $85.1K | 2 | 4.3% |
Micro Labs Limited exports Diphenhydramine to 3 countries. The largest destination is UNITED STATES accounting for 90.6% of Micro Labs Limited's Diphenhydramine shipments, followed by UNITED STATES OF AMERICA (5.1%) and UNITED ARAB EMIRATES (4.3%). These destinations reflect Micro Labs Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Diphenhydramine from Micro Labs Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| CARDINAL 3PL | UNITED STATES | $1.9M | 38 |
| MICROSYNERGY PHARMACEUTICALS FZCO | UNITED ARAB EMIRATES | $85.1K | 2 |
Micro Labs Limited supplies Diphenhydramine to 2 buyers globally. The largest buyer is CARDINAL 3PL (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Diphenhydramine Export Value and How Much Does Micro Labs Limited Contribute?
India exported $21.8M worth of Diphenhydramine through 1,430 shipments from 178 suppliers to 82 countries, serving 289 buyers globally. Micro Labs Limited contributes $1.9M to this total, accounting for 5.9% of India's Diphenhydramine exports. Micro Labs Limited ships Diphenhydramine to 3 countries through 2 buyers.
What Is the Average Shipment Value for Micro Labs Limited's Diphenhydramine Exports?
Micro Labs Limited's average Diphenhydramine shipment value is $50.0K per consignment, based on 38 shipments totaling $1.9M. The largest destination is UNITED STATES (90.6% of Micro Labs Limited's Diphenhydramine exports).
How Does Micro Labs Limited Compare to Other Indian Diphenhydramine Exporters?
Micro Labs Limited ranks #2 among 178 Indian Diphenhydramine exporters with a 5.9% market share. The top 3 exporters are ELYSIUM PHARMACEUTICALS LTD ($6.1M), REAL DRUGS PRIVATE LIMITED ($2.7M), GRANULES INDIA LIMITED ($2.5M). Micro Labs Limited processed 38 shipments to 2 destination countries.
What Diphenhydramine Formulations Does Micro Labs Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| DIPHENHYDRAMINE HCL INJECTION USP 50mg/m | $250.0K | 5 |
| DIPHENHYDRAMINE HCL INJECTION USP 50MG/M | $150.0K | 3 |
| DIPHENHYDRAMINE HCL INJECTION USP 50MG/ML ( 25X1ML ) ( QTY- 25294.000 )PCS | $150.0K | 3 |
| DIPHENHYDRAMINE HYDROCHLORIDE INJECTIONUSP 50MG/ML (25X1ML) - TAX INVOICE NO: 714201047 DT: 29.04.2024 | $150.0K | 3 |
| DIPHENHYDRAMINE HCL INJECTION USP 50MG/ML (5X1ML) - TAX INVOICE NO: 714201041 DT: 22.04.2024 | $142.9K | 3 |
| DIPHENHYDRAMINE HYDROCHLORIDE INJECTION | $50.0K | 1 |
| DIPHENHYDRAMINE HCL INJECTION USP 50mg ml 25X1ML QTY 14020 000 | $50.0K | 1 |
| DIPHENHYDRAMINE HCL INJECTION USP 50mg ml 5X1ML QTY 23688 000 | $50.0K | 1 |
| DIPHENHYDRAMINE HYDROCHLORIDE INJECTIONUSP 50MG/ML( 25X1ML ) ( QTY-6398.000 ) | $50.0K | 1 |
| DIPHENHYDRAMINE HCL INJECTION USP 50MG/ML( 25X1ML ) ( QTY- 18845.000 ) | $50.0K | 1 |
Micro Labs Limited exports 28 distinct Diphenhydramine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DIPHENHYDRAMINE HCL INJECTION USP 50mg/m with 5 shipments worth $250.0K.
Regulatory Requirements: Exporting Diphenhydramine to Key Markets
What Micro Labs Limited must comply with to export Diphenhydramine to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Micro Labs Limited Compare to Nearest Diphenhydramine Exporters?
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | GRANULES INDIA LIMITED | $2.5M | 78 | 1 | $31.9K |
| 5 | TRUECARE BIOMEDIX | $2.2M | 114 | 1 | $19.4K |
| 2 | MICRO LABS LIMITED ★ | $1.9M | 38 | 2 | $50.0K |
| 6 | ELYSIUM PHARMACEUTICALS LIMITED | $1.6M | 38 | 1 | $42.2K |
| 7 | TRUESTAR ENTERPRISE PRIVATE LIMITED | $930.0K | 27 | 3 | $34.4K |
Micro Labs Limited ranks #2 among 178 Indian Diphenhydramine exporters. Average shipment value of $50.0K compared to the market average of $122.4K. The closest competitors by value are GRANULES INDIA LIMITED and TRUECARE BIOMEDIX.
Which Indian Ports Ship Diphenhydramine Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 174 | 12.2% |
| MUNDRA SEA (INMUN1) | 130 | 9.1% |
| MUNDRA SEA | 124 | 8.7% |
| JNPT | 84 | 5.9% |
| JNPT/ NHAVA SHEVA SEA | 83 | 5.8% |
| SONEPAT ICD | 59 | 4.1% |
| SAHAR AIR | 50 | 3.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 44 | 3.1% |
Geopolitical & Trade Policy Impact on Micro Labs Limited's Diphenhydramine Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Micro Labs Limited. The Israel-Iran conflict has intensified tensions in the Red Sea, leading to increased shipping costs and potential delays. These disruptions can affect supply chain efficiency and profitability, necessitating strategic adjustments in logistics and distribution channels.
Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply sources, creating an opportunity for Indian exporters to capture a larger market share. Micro Labs can leverage this shift by emphasizing its compliance with U.S. regulatory standards and ensuring a reliable supply chain.
The recent India-European Union Free Trade Agreement, signed in January 2026, is poised to eliminate tariffs on most European pharmaceutical exports to India. While this enhances market access for European manufacturers, it also intensifies competition for Indian exporters. Micro Labs must enhance its value proposition through innovation, cost efficiency, and adherence to EU regulatory standards to maintain its competitive edge. (en.wikipedia.org)
Micro Labs Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for pharmaceutical exporters. Micro Labs Limited has demonstrated a commitment to quality, as evidenced by its recognition as India’s Most Technically and Scientifically Advanced Pharmaceutical Manufacturing Company in 2024. This accolade reflects the company's adherence to stringent manufacturing practices and international guidelines. (einnews.com)
However, the evolving regulatory landscape, including the EU's Falsified Medicines Directive and the U.S. FDA's stringent quality requirements, necessitates continuous investment in compliance infrastructure. Micro Labs must proactively adapt to these changes to ensure uninterrupted market access and maintain its reputation for quality.
About Micro Labs Limited
Micro Labs Limited exports 76 products worth $463.6M. Beyond Diphenhydramine, top products include Amoxicillin, Potassium, Gabapentin, Losartan, Esomeprazole. View the complete Micro Labs Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Diphenhydramine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Diphenhydramine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Micro Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 40 individual customs records matching Micro Labs Limited exporting Diphenhydramine, covering 28 formulations to 3 countries via 2 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 82+ countries, 289+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Diphenhydramine Export Data from Micro Labs Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Micro Labs Limited's Diphenhydramine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Micro Labs Limited
Full Company Profile →
76 products · $463.6M total trade · 21 categories
Diphenhydramine Stats
Company Overview
Top Products by Micro Labs Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Micro Labs Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Diphenhydramine. For current shipment-level data, contact TransData Nexus.